PMA device
Vns Therapy Aspiresr
LivaNova USA, Inc. · Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ, Class III) · First FDA decision May 29, 2015, newest May 29, 2015DepressionEpilepsy
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Vns Therapy Aspiresr"
MAUDE reports
0
Brand "Vns Therapy Aspiresr", since 2015
PubMed studies
0
Mentioning "Vns Therapy Aspiresr"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vns Therapy Aspiresr
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Phrenic Nerve StimulatorNational determinationOn the books160.19Updated Jun 12, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Vns Therapy Aspiresr", any status and sponsor, newest update first.
Cyberonics, Inc.Public (LIVN)
NCT01325623 · 31 participants · Start Mar 2011 · Primary completion Jul 2013
Device: Model 106 VNS Therapy System · For: Epilepsy
Sites: Anderlecht, Belgium; Brussels, Belgium; Ghent, Belgium · 14 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vns Therapy Aspiresr", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LYJ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1067-2025 · Started Jan 3, 2025 · Posted by FDA Jan 30, 2025
Reason given: Their is a potential that implanted pulse generators may stop delivering therapy due to an internal component issue.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
Z-1068-2025 · Started Jan 3, 2025 · Posted by FDA Jan 30, 2025
Reason given: Their is a potential that implanted pulse generators may stop delivering therapy due to an internal component issue.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
- SenTiva, REF: 1000; SenTiva Duo, REF: 1000-D; Generators Part of the VNS Therapy System. Used for Vagus Nerve Stimulation (VNS).Open, Classified
Z-1072-2025 · Started Dec 12, 2024 · Posted by FDA Jan 31, 2025
Reason given: Vagus nerve stimulator generators may stop delivering stimulation due to an internal, mechanically activated component that may become stuck in a closed position, which may result in patients returning to baseline seizure frequency or depressive symptoms and in the longer term, patients may be required to undergo...
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
27 more recall records with a free account
Published research
The most relevant PubMed records for "Vns Therapy Aspiresr"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LYJ.
- VNS Therapy SystemLivaNova USA, Inc. · PMA 2026
- Neurocybernetic Prosthesis (Ncp) SystemLivaNova USA, Inc. · PMA 2004
- Demipulse Model 103LivaNova USA, Inc. · PMA 2016
- Pulse, PulseDuo, DemiPulse, DemiPulseDuo, AspireHC, Aspire SR Generators.LivaNova USA, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.